Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Por um escritor misterioso
Descrição
Structure-based discovery of thiosemicarbazones as SARS-CoV-2 main
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease
IJMS, Free Full-Text
Development of highly potent non-covalent inhibitors of SARS-CoV-2
Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel
Targeting SARS-CoV-2 papain-like protease in the postvaccine era
Design, synthesis and in vitro evaluation of novel SARS-CoV-2
Frontiers Structural Basis of Potential Inhibitors Targeting
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
de
por adulto (o preço varia de acordo com o tamanho do grupo)
